#Xeljanz copay card professional#

Offer subject to change or discontinuance without notice. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Program provides for SKYRIZI® (risankizumab-rzaa) at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Patients must have a valid prescription for SKYRIZI® (risankizumab-rzaa) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. To learn about AbbVie’s privacy practices and your privacy choices, visit ‡ Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. This assistance offer is not health insurance. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed 'maximizer' programs) will have an annual maximum program benefit of $6,000.00 per calendar year.

Restrictions, including monthly maximums, may apply. Patients may not seek reimbursement for value received from the Skyrizi Complete program from any third-party payers. Patients residing in or receiving treatment in certain states may not be eligible.

If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Skyrizi Complete Savings Card and patient must call Skyrizi Complete at 1.866.SKYRIZI to stop participation. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. Eligibility: Available to patients with commercial prescription insurance coverage for SKYRIZI who meet eligibility criteria. This benefit covers SKYRIZI® (risankizumab-rzaa). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

#Xeljanz copay card professional#

*Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP).

The Skyrizi Complete Nurse Ambassadors have an average of more than 19 years of experience 2Ĭall 1-866-SKYRIZI (1-86) to have your patient connect with a Nurse Ambassador.

Helping patients understand their roles in coordinating their treatment (including the delivery of their medication to their doctor’s office in time for their next injection).

Providing training to complement the training you have given them, along with supplemental injection training resources.

Helping patients make sense of their insurance coverage, helping them find ways to save on prescription costs, and connecting them with additional insurance expertise and resources designed around their prescribed treatment plan.

Answering questions throughout the injection experience to help avoid disruptions.

Nurse Ambassadors provide 1:1 support to help meet the unique needs of each individual patient, including: Our Nurse Ambassadors are the heart of SKYRIZI Complete